Data Report

On the one hand, an unfortunate development but, on the other hand, completely understandable given the circumstances.

Pfizer & Moderna dominated the initial market in the US and, subsequently, never relinquished it. J&J had an initial advantage being only one shot and also capable of not needing special cold storage. However, factors such as limited vaccine acceptance & it's initial problems with manufacturing ultimately doomed it.